Clinical trials
Psoriasis Vulgaris clinical trials
Below are recruiting psoriasis vulgaris clinical trials, each written for real people, not researchers. We’re tracking 11 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT07320872Recruiting
Vaspin gene and blood levels in psoriasis patients
This study looks at the relationship between a gene (Vaspin) and the level of the Vaspin protein in the blood of people with psoriasis. It aims to help understand how psoriasis works and may point to new ways to treat it.
AswānAges 18–50 - NCT06887322Enrolling by invitationPhase 1/Phase 2
Herbal cream for plaque psoriasis
This study tests an herbal cream made from Ciplukan (a plant) on plaque psoriasis. If you are an adult with mild-to-moderate psoriasis and are not already using other treatments, this trial may help find a gentler option.
Bandung, West JavaAges 18–60 - NCT04950218Recruiting
Study risks of heart problems in people with psoriasis
This study asks adults with psoriasis about factors that may be linked to heart problems. It aims to better understand who is at higher risk, which could help guide future prevention and care.
Hellerup, CopenhagneAges 18 years+ - NCT07426120RecruitingPhase 3
Coumarin cream for psoriasis: a research study
This study tests a cream made from a natural plant compound (coumarin) to see if it can help treat plaque psoriasis. If you have mild-to-moderate psoriasis and haven't used certain other treatments recently, this trial may be an option for you.
New York, New YorkAges 18–70 - NCT06398106RecruitingPhase 4
Proactive monitoring vs. standard use of biologics for psoriasis
This study compares a proactive approach (adjusting drug levels based on regular blood tests) versus the usual way of using biologics for psoriasis. It helps see if active monitoring can improve treatment while keeping you safe.
BrugesAges 18 years+ - NCT05815797RecruitingPhase 2
Chinese herbal formula for mild to moderate psoriasis
This trial tests an herbal formula called Shuiniujiao Dihuang Decoction for people with mild to moderate plaque psoriasis. It may help reduce psoriasis symptoms without using stronger medicines.
Hong KongAges 18–75 - NCT06801821Recruiting
Stigma study on skin conditions
This study looks at how people view those with certain skin conditions. It aims to understand stigma, which may help improve awareness and support.
Roma, ItaliaAges 18 years+ - NCT04080635Recruiting
Check how to monitor brodalumab blood levels in psoriasis
This study measures brodalumab levels in your blood to see whether “therapeutic drug monitoring” can guide treatment in people with plaque psoriasis. If you’re eligible, it may help doctors better match the medicine to your body.
Ghent, Oost-VlaanderenAges 18 years+ - NCT05390515RecruitingPhase 4
Study immune response in adults with psoriasis on tildrakizumab
This trial studies how the immune system responds in adults with moderate-to-severe psoriasis when receiving tildrakizumab. The goal is to better understand treatment effects and immune changes, which may help improve care for people with psoriasis.
San Francisco, CaliforniaAges 18–75 - NCT05858645RecruitingPhase 4
Deucravacitinib to correct immune signals in psoriasis
This Phase 4 study tests whether deucravacitinib can improve psoriasis by correcting abnormal immune-cell signals seen in people with moderate-to-severe disease. It may help reduce symptoms and improve control of psoriasis, while researchers also track immune changes.
San Francisco, CaliforniaAges 18–75 - NCT07250997Recruiting
PALLAS laser study for skin conditions
This trial tests a new laser (PALLAS) that delivers targeted UVB light to treat skin conditions like psoriasis or eczema. It may help if your doctor thinks your skin problem could improve with UVB therapy.
Szeged, Csongrád-Csanád VármegyeAges 18–65
Hear when a new Psoriasis Vulgaris trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for psoriasis vulgaris?
- Yes. Clin2 currently lists 11 recruiting psoriasis vulgaris studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a psoriasis vulgaris trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a psoriasis vulgaris trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.